
Ivermectol 6mg (Ivermectin) in Kenya
KSh 4,500.00
Ivermectol 6mg contains ivermectin, an antiparasitic medication used to treat strongyloidiasis (intestinal roundworm), onchocerciasis (river blindness), scabies, and lice. It works by paralyzing and killing parasites. Available as 6mg tablets in Kenya, it is prescription-only for parasitic infections. Note: Not approved for COVID-19 prevention/treatment by WHO or Kenyan MOH.
Add to cart
Buy Now
Product Description
Overview
Ivermectol 6mg contains ivermectin, an antiparasitic medication used to treat strongyloidiasis (intestinal roundworm), onchocerciasis (river blindness), scabies, and lice. It works by paralyzing and killing parasites. Available as 6mg tablets in Kenya, it is prescription-only for parasitic infections. Note: Not approved for COVID-19 prevention/treatment by WHO or Kenyan MOH.
Composition
- Active Ingredient: Ivermectin 6mg per tablet.
- Form: White, round, scored tablets.
- Inactive Ingredients: Microcrystalline cellulose, pregelatinized starch, butylated hydroxyanisole, citric acid.
Side Effects
Common
- Gastrointestinal: Nausea, diarrhea, abdominal pain.
- Neurological: Dizziness, drowsiness.
- Dermatological: Itching, rash (especially in onchocerciasis due to parasite death).
Serious Risks
- Hypotension: Low blood pressure (risk in high-burden infections).
- Neurotoxicity: Seizures, encephalopathy (rare; higher risk in Loa loa co-infection).
- Liver Injury: Elevated liver enzymes (monitor in hepatic impairment).
- Allergic Reactions: Swelling, breathing difficulties (discontinue immediately).
How to Use
Dosing Guidelines
|
Condition
|
Dosage
|
Duration
|
|---|---|---|
| Strongyloidiasis | 200µg/kg (max 12mg) once daily for 1–2 days | 1–2 days |
| Onchocerciasis | 150µg/kg (max 12mg) once every 6–12 months | Single dose |
| Scabies | 200µg/kg (max 12mg) once; repeat after 14 days | 2 doses |
| Lice | 200µg/kg (max 12mg) once; repeat after 7–10 days | 2 doses |
Administration
- Take on an empty stomach with water (1 hour before/2 hours after meals).
- Weight-Based Dosing:
- 15–24 kg: 3mg (½ tablet).
- 25–35 kg: 6mg (1 tablet).
- 36–50 kg: 9mg (1½ tablets).
- 51–65 kg: 12mg (2 tablets).
- >65 kg: 150µg/kg (max 12mg).
- Precautions:
- Avoid if: Loa loa co-infection (risk of severe reactions), hepatic impairment, pregnancy.
- Drug Interactions:
- Warfarin: Increased anticoagulant effect (monitor INR).
- Anticonvulsants (e.g., phenytoin): Reduced ivermectin efficacy.
Frequently Asked Questions
-
Is Ivermectol available over-the-counter in Kenya?
No – prescription-only for parasitic infections. -
How much does it cost?
~KES 200–500 per 6mg tablet (varies by pharmacy). -
Does NHIF cover it?
Partially – covered for onchocerciasis/strongyloidiasis in endemic areas. -
Can it be used for COVID-19?
No – WHO/Kenya MOH do not recommend due to lack of efficacy evidence. -
What if I miss a dose?
Take as soon as remembered; skip if near next dose. Never double-dose. -
Are there Kenyan alternatives?
Yes – Ivermectin generics (e.g., Ivermec, Scabperal) cost KES 100–300/tablet. -
Is it safe for children?
Yes – weight-based dosing for children ≥15kg. -
How to manage itching after onchocerciasis treatment?
Use antihistamines (e.g., cetirizine) – temporary due to parasite death.
Conclusion
Ivermectol 6mg is a critical tool against neglected tropical diseases in Kenya, particularly in endemic regions (e.g., Rift Valley for onchocerciasis, arid areas for strongyloidiasis). Its low cost and single-dose efficacy make it invaluable, but prescription-only status ensures appropriate use. Key challenges include Loa loa co-infection risks (requiring screening) and misuse for non-parasitic conditions. For scabies/lice, permethrin creams remain first-line, but ivermectin is vital for severe/crusted cases. Always adhere to weight-based dosing and avoid self-medication. In Kenya’s fight against parasitic diseases, Ivermectol saves lives but demands responsible use under medical guidance.
Be the first to review “Ivermectol 6mg (Ivermectin) in Kenya” Cancel reply



Reviews
There are no reviews yet.